摘要:
At least one compound chosen from compounds of Formula I: a pharmaceutically acceptable salt or ester thereof, a solvate thereof, a chelate thereof, a non-covalent complex thereof, a prodrug thereof, and mixtures of any of the foregoing, wherein: n is a number from 1 to 900, wherein the individual units may be the same or different; W is chosen from alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, aralkyl and substituted aralkyl; each of R2, R3, R4 and R5 is independently chosen from —H, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, aralkyl and substituted aralkyl; Z′ is chosen from —O—, —N—, —NO—, —NR4—, —S—, —SO— and —SO2—, wherein R4 is defined as above; each of X, X′, Y and Z is independently chosen from —CR4R5—, —NH—, —NR4—, —NO—, —O—, —NOR4—, —S—, —SO—, —SO2—, wherein R4 and R5 are defined as above; R1 is chosen from a tocopherol, a steroid and a flavonoid; and R6 is chosen from any R1, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl, substituted aryl, aralkyl and substituted aralkyl.
摘要翻译:至少一种选自式I化合物的化合物:其药学上可接受的盐或酯,其溶剂化物,其螯合物,其非共价复合物,其前药,以及任何前述物质的混合物,其中:n为 1至900的数字,其中各个单元可以相同或不同; W选自烷基,取代的烷基,环烷基,取代的环烷基,芳基,取代的芳基,芳烷基和取代的芳烷基; R 2,R 3,R 4和R 5中的每一个独立地选自-H,烷基, 取代的烷基,环烷基,取代的环烷基,芳基,取代的芳基,芳烷基和取代的芳烷基; Z'选自-O - , - N-,-NO - , - NR 4 - , - S - , - SO-和-SO 2 - ,其中 R 4如上定义; X,X',Y和Z中的每一个独立地选自-CR 4 R 5 - , - NH - , - NR 4 - ,-NO - , - O - , - NOR 4 - , - S - , - SO - , - SO 2 - ,其中R 4 SUB >和R 5定义如上; R 1选自生育酚,类固醇和类黄酮; R 6选自任何R 1,C 1,C 1,C 3,C 6烷基,取代的烷基,环烷基,取代的环烷基,芳基,取代的芳基,芳烷基和取代的芳烷基。
摘要:
The present invention provides a solid sucrose acetate isobutyrate (SAIB) formulation, comprising sucrose acetate isobutyrate in an amount from about 1 weight percent to about 80 weight percent based on the total weight percent of the total solid formulation; and a solid substrate that is soluble in water or oil, wherein the substrate is present in an amount from about 99 weight percent to about 30 weight percent based on the weight of the formulation, wherein the formulation is pourable in less than about 20 seconds according to ASTM method D1895-96. The SAIB formulation is useful in beverage applications.
摘要:
The present invention provides a process for producing a solid sucrose acetate isobutyrate (SAIB) formulation, by combining sucrose acetate isobutyrate in an amount from about 1 weight percent to about 80 weight percent based on the total weight percent of the total solid formulation; and a solid substrate that is soluble in water or oil, wherein the substrate is present in an amount from about 99 weight percent to about 30 weight percent based on the weight of the formulation, wherein the formulation produced is pourable in less than about 20 seconds according to ASTM method D1895-96. The solid SAIB formulation is useful in beverage applications.
摘要:
Disclosed is a process for the recovery of a phytolipid composition from a vegetable oil by-product. The phytolipid composition produced comprises squalene, phytosterols, mixed tocopherols and tocotrieneols, and vegetable wax and is useful as an emollient. The phytochemical composition may be applied directly to the skin to provide emolliency. Alternatively, the phytolipid composition may be formulated in various aqueous or anhydrous cosmetic compositions such as creams, lotions, gels, ointments, lip balms, sticks, or pencils for treatment of the skin and lips. The phytolipid composition also may be incorporated into foods, beverages, and nutraceuticals to provide health benefits.
摘要:
Compounds and compositions are disclosed for increasing the bioavailability of lipophilic drugs, and more specifically, to solubilizing lipophilic drugs using bioenhancers that cause no efflux inhibition or a desired degree of efflux inhibition. Methods of making and using such compositions are also disclosed.
摘要:
Disclosed is a process for the recovery of a phytolipid composition from a vegetable oil by-product. The phytolipid composition produced comprises squalene, phytosterols, mixed tocopherols and tocotrieneols, and vegetable wax and is useful as an emollient. The phytochemical composition may be applied directly to the skin to provide emolliency. Alternatively, the phytolipid composition may be formulated in various aqueous or anhydrous cosmetic compositions such as creams, lotions, gels, ointments, lip balms, sticks, or pencils for treatment of the skin and lips. The phytolipid composition also may be incorporated into foods, beverages, and nutraceuticals to provide health benefits.